FDA Brief

Warning letters Biologics

FDA warning letter to

Mother Stem Institute, Corp.

Issued Aug 20, 2024Posted Sep 3, 2024Center for Biologics Evaluation and Research (CBER)

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). We haven't summarized this letter yet. Read it on fda.gov.